Johnson & Johnson Is a King of Dividend Safety [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
The healthcare giant generates durable cash flow and has a fortress-like balance sheet . These features put its 3.4% yielding dividend on a rock-solid foundation. Here's why those seeking a bankable income stream should invest in Johnson & Johnson Backed by the full faith and credit of Johnson & Johnson Johnson & Johnson is one of only two companies in the world with a AAA bond rating from two or more credit rating agencies; Microsoft is the other. That's better than the U.S. federal government, which only has one AAA rating remaining . The company's prime credit rating means it has an extremely strong capacity to meet its financial obligations. The company boasts a fortress-like balance sheet. It ended the first quarter with $26 billion of cash and marketable securities against $34 billion in debt. With a mere $7 billion of net debt, Johnson & Johnson has an extremely low leverage ratio . Last year, it generated free cash flow of $18 billion, enough to cover its net debt twic
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M [Yahoo! Finance]Yahoo! Finance
- How Much Money Can I Get From The Hair Relaxer Lawsuit? [Forbes]Forbes
- Best Los Angeles Mesothelioma Lawyers Of 2024 [Forbes]Forbes
- Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.MarketBeat
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/15/24 - Form 424B2
- 5/14/24 - Form FWP
- 5/14/24 - Form 424B5
- JNJ's page on the SEC website